Kelley A, Shunkarova M, Maestas M, Gale S, Hogrebe N, Millman J
bioRxiv. 2024; .
PMID: 39605713
PMC: 11601561.
DOI: 10.1101/2024.11.19.624394.
Wang Q, Huang Y, Liu L, Zhao X, Sun Y, Mao X
Front Immunol. 2024; 15:1391504.
PMID: 38887292
PMC: 11180903.
DOI: 10.3389/fimmu.2024.1391504.
Raoufinia R, Rahimi H, Saburi E, Moghbeli M
J Transl Med. 2024; 22(1):435.
PMID: 38720379
PMC: 11077715.
DOI: 10.1186/s12967-024-05226-3.
Liao C, Guan Y, Zheng J, Wang X, Wang M, Zhu Z
Biol Res. 2023; 56(1):59.
PMID: 37951961
PMC: 10638775.
DOI: 10.1186/s40659-023-00471-0.
Bora J, Dey A, Lyngdoh A, Dhasmana A, Ranjan A, Kishore S
Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3459-3481.
PMID: 37522916
DOI: 10.1007/s00210-023-02631-1.
Enrichment of stem cell-derived pancreatic beta-like cells and controlled graft size through pharmacological removal of proliferating cells.
Shilleh A, Beard S, Russ H
Stem Cell Reports. 2023; 18(6):1284-1294.
PMID: 37315522
PMC: 10277834.
DOI: 10.1016/j.stemcr.2023.05.010.
Pancreatic β-cell heterogeneity in adult human islets and stem cell-derived islets.
Aldous N, Moin A, Abdelalim E
Cell Mol Life Sci. 2023; 80(6):176.
PMID: 37270452
PMC: 10239390.
DOI: 10.1007/s00018-023-04815-7.
Human pluripotent stem cell-derived β cells: Truly immature islet β cells for type 1 diabetes therapy?.
Jiang H, Jiang F
World J Stem Cells. 2023; 15(4):182-195.
PMID: 37180999
PMC: 10173812.
DOI: 10.4252/wjsc.v15.i4.182.
The Values and Perspectives of Organoids in the Field of Metabolic Syndrome.
Tan C, Ding M, Zheng Y
Int J Mol Sci. 2023; 24(9).
PMID: 37175830
PMC: 10179392.
DOI: 10.3390/ijms24098125.
Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes.
Hogrebe N, Ishahak M, Millman J
Cell Stem Cell. 2023; 30(5):530-548.
PMID: 37146579
PMC: 10167558.
DOI: 10.1016/j.stem.2023.04.002.
Single-cell transcriptome analysis of NEUROG3+ cells during pancreatic endocrine differentiation with small molecules.
Li J, Chen J, Luo X, Lu G, Lin G
Stem Cell Res Ther. 2023; 14(1):101.
PMID: 37098639
PMC: 10127065.
DOI: 10.1186/s13287-023-03338-z.
Single-cell profiling of GP2-enriched pancreatic progenitors to simultaneously create acinar, ductal, and endocrine organoids.
Merz S, Breunig M, Melzer M, Heller S, Wiedenmann S, Seufferlein T
Theranostics. 2023; 13(6):1949-1973.
PMID: 37064874
PMC: 10091881.
DOI: 10.7150/thno.78323.
Revisiting the Pathogenesis of Type 1 Diabetes: Importance of Neural Input to Pancreatic Islets and the Therapeutic Capability of Stem Cell Educator Therapy to Restore Their Integrity.
Zhao Y, Veysman B
Biomedicines. 2023; 11(2).
PMID: 36831130
PMC: 9952924.
DOI: 10.3390/biomedicines11020594.
Type 1 : A Review on Advances and Challenges in Creating Insulin Producing Devices.
Rodrigues Oliveira S, Rebocho A, Ahmadpour E, Nissapatorn V, Pereira M
Micromachines (Basel). 2023; 14(1).
PMID: 36677212
PMC: 9867263.
DOI: 10.3390/mi14010151.
Downstream bioprocessing of human pluripotent stem cell-derived therapeutics.
Sart S, Liu C, Zeng E, Xu C, Li Y
Eng Life Sci. 2022; 22(11):667-680.
PMID: 36348655
PMC: 9635003.
DOI: 10.1002/elsc.202100042.
Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes.
Pellegrini S, Zamarian V, Sordi V
Transpl Int. 2022; 35:10575.
PMID: 36090777
PMC: 9448870.
DOI: 10.3389/ti.2022.10575.
Treating iPSC-Derived β Cells with an Anti-CD30 Antibody-Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation.
Pellegrini S, Zamarian V, Landi E, Cospito A, Lombardo M, Manenti F
Int J Mol Sci. 2022; 23(17).
PMID: 36077097
PMC: 9456216.
DOI: 10.3390/ijms23179699.
Stepwise differentiation of functional pancreatic β cells from human pluripotent stem cells.
Jin W, Jiang W
Cell Regen. 2022; 11(1):24.
PMID: 35909206
PMC: 9339430.
DOI: 10.1186/s13619-022-00125-8.
Overcoming the Limitations of Stem Cell-Derived Beta Cells.
Karimova M, Gvazava I, Vorotelyak E
Biomolecules. 2022; 12(6).
PMID: 35740935
PMC: 9221417.
DOI: 10.3390/biom12060810.
GP2-enriched pancreatic progenitors give rise to functional beta cells in vivo and eliminate the risk of teratoma formation.
Aghazadeh Y, Sarangi F, Poon F, Nkennor B, McGaugh E, Nunes S
Stem Cell Reports. 2022; 17(4):964-978.
PMID: 35364010
PMC: 9023812.
DOI: 10.1016/j.stemcr.2022.03.004.